Medication Errors and Adverse Drug Events (ADEs) in Ambulatory Pediatrics

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Agency for Healthcare Research and Quality (AHRQ).
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Brigham and Women's Hospital
Children's Hospital Boston
The Commonwealth Fund
Information provided by:
Agency for Healthcare Research and Quality (AHRQ)
ClinicalTrials.gov Identifier:
NCT00229671
First received: September 28, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

The purpose of this study is to determine the rates of medication errors in pediatric outpatients in 6 office practices. Further, we wish to determine the effectiveness of a computerized physician order entry (CPOE) system in reducing errors.


Condition Intervention
Pediatric Patients With a Variety of Medical Conditions.
Device: Computerized Physician Order Entry

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Ambulatory Medication Errors and Adverse Drug Events (ADEs) in Pediatrics

Resource links provided by NLM:


Further study details as provided by Agency for Healthcare Research and Quality (AHRQ):

Primary Outcome Measures:
  • Medication Errors
  • Adverse Drug Events

Estimated Enrollment: 30000
Study Start Date: September 2001
Estimated Study Completion Date: July 2005
Detailed Description:

This study has the following 2 goals:

Aim 1: To determine the rates, types, and predictors of medication errors and ADEs.

Aim 2: To perform a trial assessing the effectiveness of an intervention (CPOE) on reducing serious medication errors.

We hypothesize that:

  1. Medication errors and ADEs are frequent in ambulatory pediatrics.
  2. Presence of the following predictors will be associated with higher error rates: cultural, racial, socioeconomic, educational, and linguistic barriers to communication, understanding, and successful completion of prescribed therapies; complex medical or chronic medical conditions; complex medication regimens; non-physician providers with limited clinical experience; high provider workloads; and complex prescription refill systems.
  3. Prevention strategies, including both technology-based and behavioral/ human factors-based interventions, will be effective and cost-effective in reducing rates of serious medication errors (defined as preventable ADEs and non-intercepted potential ADEs).
  Eligibility

Ages Eligible for Study:   up to 21 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Pediatric providers at the participating office practices during the study period as well as the parents of the patients of these providers.

Exclusion Criteria:

  • Pediatric providers or patients at other office practices.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00229671

Contacts
Contact: Carol Keohane 617 525 6660 ckeohane@partners.org

Locations
United States, Massachusetts
Brigham and Women's Hospital Recruiting
Boston, Massachusetts, United States, 02120
Contact: Carol Keohane    617-525-6669    ckeohane@partners.org   
Contact: Rainu Kaushal    212 746 1703    rkaushal@partners.org   
Principal Investigator: Rainu Kaushal         
Sponsors and Collaborators
Brigham and Women's Hospital
Children's Hospital Boston
The Commonwealth Fund
Investigators
Principal Investigator: Rainu Kaushal Brigham and Women's Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00229671     History of Changes
Other Study ID Numbers: 5 P01 HS11534-03, 2002-P-000544/41; BWH
Study First Received: September 28, 2005
Last Updated: September 28, 2005
Health Authority: United States: Federal Government

ClinicalTrials.gov processed this record on October 01, 2014